Investor mix
5 investors on record; lead investors include Amadeus Capital; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Private equity | 1 | 20% |
Develops Genome sequencing technology
5 investors on record; lead investors include Amadeus Capital; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Private equity | 1 | 20% |